UBS AG, London Branch Share Price

Certificat

W9VCA2

DE000UE9VCA2

Real-time Borsa Italiana 10:32:39 05/07/2024 BST
87.68 EUR +0.80% Intraday chart for UBS AG, London Branch
Current month+2.27%
1 month-2.21%
Date Price Change
05/07/24 87.68 +0.80%
04/07/24 86.98 +0.17%
03/07/24 86.83 +0.44%
02/07/24 86.45 -0.37%
01/07/24 86.77 +2.02%

Real-time Borsa Italiana

Last update July 05, 2024 at 10:32 am

More quotes

Static data

Product typeCertificats Divers
Buy / SellCALL
Underlying SANOFI
Issuer UBS
W9VCA2
ISINDE000UE9VCA2
Date issued 14/06/2021
Maturity 15/06/2026 (711 Days)
Parity 0.85 : 1
Emission price 100
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 102
Lowest since issue 50.85

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.78%
Consensus
  1. Stock Market
  2. Certificates
  3. W9VCA2 Certificat